Lanthanum Carbonate Tablet, Chewable
Product Images NDC 66993-423

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lanthanum Carbonate (NDC 66993-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lanthanum 01)

Figure 1 (Lanthanum 01)
A line graph showing the difference in phosphorus reduction (mg/dl) versus placebo at various Lanthanum Carbonate doses (225 mg, 675 mg, 1350 mg, and 2250 mg). The y-axis represents the difference in phosphorus levels, with error bars indicating variability at each dose level.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Package)

Principal Display Panel (500 mg Tablet Bottle Package)
Packaging label for Lanthanum Carbonate 500 mg chewable tablets by Prasco Laboratories. The label states the product contains 2 bottles, each with 45 tablets, and emphasizes not swallowing tablets whole but chewing or crushing before swallowing. It includes storage instructions, active and inactive ingredients, and a barcode. This is a prescription oral chewable tablet product.*
FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Package)

Principal Display Panel (750 mg Tablet Bottle Package)
Lanthanum carbonate 750 mg chewable tablets packaging label by Prasco Laboratories. The label highlights the active ingredient lanthanum carbonate hydrate and instructs users not to swallow tablets whole, but to chew or crush completely before swallowing. It shows a package size of 6 bottles, each containing 15 chewable tablets. The label includes storage instructions and distributor information, emphasizing that it is Rx only.*
FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Package)

Principal Display Panel (1000 mg Tablet Bottle Package)
Lanthanum Carbonate 1000 mg chewable tablets packaging from Prasco Laboratories. The label indicates 9 bottles containing 10 chewable tablets each. Instructions warn not to swallow tablets whole, to chew or crush completely before swallowing, and to take with or immediately after meals. The label includes active and inactive ingredient information and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.